Letrozole better than tamoxifen in postmenopausal women

被引：6
|
作者：
Fricker, J
机构：
来源：
LANCET ONCOLOGY | 2005年 / 6卷 / 03期
关键词：
D O I：
10.1016/S1470-2045(05)01758-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [1] Letrozole in postmenopausal women after five years on tamoxifen
    Edith A. Perez
    [J]. Current Oncology Reports, 2004, 6 (1) : 74 - 74
  • [2] A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer
    Thürlimann, B
    Keshaviah, A
    Coates, AS
    Mouridsen, H
    Mauriac, L
    Forbes, JF
    Paridaens, R
    Castiglione-Gertsch, M
    Gelber, RD
    Rabaglio, M
    Smith, I
    Wardly, A
    Price, KN
    Goldhirsch, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (26): : 2747 - 2757
  • [3] Raloxifene is a better antioxidant of low-density lipoprotein than estradiol or tamoxifen in postmenopausal women in vitro
    Arteaga, E
    Villaseca, P
    Bianchi, M
    Rojas, A
    Marshall, G
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (02): : 142 - 146
  • [4] Letrozole reduces spread of early breast cancer after tamoxifen therapy in postmenopausal women
    不详
    [J]. ONCOLOGY-NEW YORK, 2004, 18 (09): : 1156 - +
  • [5] Impact of tamoxifen on the pharmacokinetics and endocrine effects of the aromatase inhibitor letrozole in postmenopausal women with breast cancer
    Dowsett, M
    Pfister, C
    Johnston, SRD
    Miles, DW
    Houston, SJ
    Verbeek, JA
    Gundacker, H
    Sioufi, A
    Smith, IE
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (09) : 2338 - 2343
  • [6] Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer
    Ingle, JN
    Suman, VJ
    Johnson, PA
    Krook, JE
    Mailliard, JA
    Wheeler, RH
    Loprinzi, CL
    Perez, EA
    Jordan, VC
    Dowsett, M
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 (07) : 1642 - 1649
  • [7] Moexipril is better tolerated than hydrochlorothiazide in postmenopausal women with hypertension
    Stimpel, M
    Koch, B
    [J]. HYPERTENSION, 1997, 29 (03) : 25 - 25
  • [8] Cost Effectiveness of Extended Adjuvant Letrozole in Postmenopausal Women after Adjuvant Tamoxifen TherapyThe UK Perspective
    Jonathan Karnon
    Thomas Delea
    Stephen R. D. Johnston
    Robert Smith
    Jane Brandman
    Jennifer Sung
    Paul E. Goss
    [J]. PharmacoEconomics, 2006, 24 : 237 - 250
  • [9] A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer (vol 353, pg 2747, 2005)
    Wardley, A
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (20): : 2200 - 2200
  • [10] Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy - The UK perspective
    Karnon, J
    Delea, T
    Johnston, SRD
    Smith, R
    [J]. PHARMACOECONOMICS, 2006, 24 (03) : 237 - 250
12345